4,9-Dibromonaphtho[2,3-c][1,2,5]selenadiazole, 95%, 250mg

2-((6-Chloro-2-methylpyrimidin-4-yl)amino)-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide, 98.00%, 10g

4-cyclohexyl-4-hydroxybut-3-en-2-one, 95%, 5g

(R)-1-(2-(Trifluoromethyl)phenyl)ethanamine hydrochloride, 95.0%, 1g

Warning symbol according to ISO 7010 Individual label, Hot surface, Side length 200 mm, 1 piece

1-(3,6-dibromo-9H-carbazol-9-yl)-3-(piperazin-1-yl)propan-2-ol dihydrochloride, 98%, 10mg

6-Hydroxydopamine.Hydrobromide, >90%, 10mg

Methyl 3-Bromo-2-(bromomethyl)propionate>97.0%(GC)5g

Tris(3-fluorophenyl)phosphine, 98.0%, 5g

4-(5-FLUORO-1H-INDOL-3-YL)BUTAN-1-OL, 95.0%, 1g

6-(Methoxycarbonyl)nicotinic acid, 97.0%, 1g

Methyl (Phenyl 2,3,4-Tri-O-acetyl-1-thio-beta-D-glucopyranosid)uronate>98.0%(HPLC)1g

(S)-2-Amino-1-(4-hydroxypiperidin-1-yl)propan-1-one hydrochloride, 100mg